FDA Panel to Review Moderna’s Flu Vaccine for Older Adults
The U.S. Food and Drug Administration’s (FDA) independent vaccine advisory panel is set to review and vote on whether the benefits of Moderna’s influenza vaccine, mFlusiva, outweigh its potential risks in older adults. Moderna...
Psychedelic Drug Stocks Surge After Trump Fast-Tracks Reviews and Funding
Shares of psychedelic drug developers rallied sharply in premarket trading on Monday after Donald Trump signed an executive order directing health regulators to accelerate the approval process for psychedelic-based treatments and increase federal research...